Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Brian Mueller. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Brian Mueller har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | EVP, Chief Financial Officer | 99 781 |
US:ANTH / Anthera Pharmaceuticals, Inc. | Director | 84 705 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Brian Mueller. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ANTH / Anthera Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ANTH / Anthera Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ANTH / Anthera Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Brian Mueller som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 640 | 99 781 | 20,01 | ||||
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −18 497 | 83 141 | −18,20 | 69,44 | −1 284 432 | 5 773 311 | |
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 367 | 101 638 | 10,15 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 660 | 92 271 | 11,69 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 82 611 | 15,43 | ||||
2024-07-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −588 | 71 571 | −0,81 | 82,33 | −48 410 | 5 892 440 | |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 72 159 | −6,48 | 75,19 | −375 950 | 5 425 635 |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 77 159 | 6,93 | 63,10 | 315 500 | 4 868 733 |
2024-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 300 | 72 159 | 0,42 | 68,65 | 20 594 | 4 953 427 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −20 789 | 71 859 | −22,44 | 83,87 | −1 743 573 | 6 026 814 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 400 | 92 648 | 14,03 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 103 | 81 248 | 8,12 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 8 802 | 75 145 | 13,27 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 220 | 66 343 | 43,84 | ||||
2024-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 318 | 46 123 | 0,69 | 66,88 | 21 267 | 3 084 614 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 45 805 | −1,24 | 88,93 | −51 224 | 4 073 439 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 602 | 46 381 | −9,03 | 88,93 | −409 256 | 4 124 662 | |
2023-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 602 | 46 381 | −9,03 | 88,93 | −409 256 | 4 124 662 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 973 | 55 585 | −6,67 | 93,41 | −371 118 | 5 192 195 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 708 | 59 558 | −4,35 | 87,74 | −237 600 | 5 225 619 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 630 | 62 266 | 18,30 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 250 | 52 636 | 2,43 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 980 | 51 386 | 27,17 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 660 | 40 406 | 45,63 | ||||
2023-01-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 27 746 | −8,27 | 114,50 | −286 250 | 3 176 917 |
2023-01-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 30 246 | 9,01 | 63,10 | 157 750 | 1 908 523 |
2022-12-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 27 746 | −8,27 | 107,50 | −268 750 | 2 982 695 |
2022-12-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 30 246 | 9,01 | 63,10 | 157 750 | 1 908 523 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 761 | 27 746 | −11,94 | 104,50 | −393 024 | 2 899 457 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 761 | 31 507 | 13,56 | 67,81 | 255 033 | 2 136 490 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 139 | 27 746 | −7,16 | 104,50 | −223 526 | 2 899 457 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 139 | 29 885 | 7,71 | 67,81 | 145 046 | 2 026 502 |
2022-12-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 101 | 27 746 | −3,82 | 104,50 | −115 054 | 2 899 457 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 500 | 28 847 | −10,82 | 99,50 | −348 250 | 2 870 276 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 500 | 32 347 | 12,13 | 67,81 | 237 335 | 2 193 450 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −945 | 28 847 | −3,17 | 99,50 | −94 028 | 2 870 276 |
2022-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −934 | 29 792 | −3,04 | 95,09 | −88 814 | 2 832 921 |
2022-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 500 | 30 726 | −10,23 | 94,50 | −330 750 | 2 903 607 |
2022-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 500 | 34 226 | 11,39 | 67,81 | 237 335 | 2 320 865 |
2022-07-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 337 | 30 726 | −19,28 | 89,50 | −656 662 | 2 749 977 |
2022-07-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 38 063 | −1,49 | 83,92 | −48 338 | 3 194 247 | |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −9 762 | 0 | −100,00 | |||
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 038 | 0 | −100,00 | |||
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 762 | 38 639 | −20,17 | 84,50 | −824 889 | 3 264 996 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 762 | 48 401 | 25,26 | 37,46 | 365 685 | 1 813 101 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 038 | 38 639 | −5,01 | 84,50 | −172 211 | 3 264 996 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 038 | 40 677 | 5,27 | 37,46 | 76 343 | 1 523 760 |
2022-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 340 | 38 639 | 0,89 | 62,41 | 21 218 | 2 411 344 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −582 | 38 299 | −1,50 | 80,72 | −46 979 | 3 091 495 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 26 520 | 26 520 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 868 | 38 881 | −4,58 | 78,27 | −146 208 | 3 043 216 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 40 749 | 37,16 | ||||
2022-02-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 072 | 29 709 | −3,48 | 87,77 | −94 089 | 2 607 559 | |
2021-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −576 | 30 781 | −1,84 | 83,46 | −48 073 | 2 568 982 | |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −6 709 | 0 | −100,00 | |||
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 709 | 31 357 | −17,62 | 79,50 | −533 366 | 2 492 882 |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 709 | 38 066 | 21,40 | 28,23 | 189 395 | 1 074 603 |
2021-05-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 31 357 | 1,10 | 62,41 | 21 281 | 1 956 896 | |
2021-04-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 692 | 31 016 | −15,51 | 76,30 | −434 300 | 2 366 521 |
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −516 | 36 708 | −1,39 | 78,52 | −40 516 | 2 882 312 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −582 | 37 224 | −1,54 | 77,21 | −44 936 | 2 874 065 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 24 890 | 24 890 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −994 | 37 806 | −2,56 | 78,39 | −77 920 | 2 963 612 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 110 | 38 800 | 35,24 | ||||
2021-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 17 | 29 761 | 0,06 | 62,59 | 1 064 | 1 862 622 | |
2021-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 071 | 28 673 | −3,60 | 82,82 | −88 700 | 2 374 698 | |
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 13 230 | 13 230 | |||||
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 640 | 29 744 | 18,48 | ||||
2020-06-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 323 | 25 104 | 1,30 | 62,59 | 20 215 | 1 571 159 | |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −414 | 24 781 | −1,64 | 73,05 | −30 243 | 1 810 252 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 600 | 9 600 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 730 | 25 195 | 36,45 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 303 | 18 465 | −6,59 | 84,50 | −110 104 | 1 560 292 | |
2020-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 800 | 19 768 | 41,52 | ||||
2020-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 | 13 968 | 0,06 | 62,23 | 560 | 869 215 | |
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 299 | 13 959 | 2,19 | 68,78 | 20 566 | 960 128 | |
2019-04-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 953 | 13 660 | −17,78 | 94,00 | −277 582 | 1 284 040 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −415 | 16 613 | −2,44 | 88,05 | −36 541 | 1 462 775 | |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 650 | 9 650 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 780 | 17 028 | 51,39 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 149 | 11 248 | −9,27 | 94,53 | −108 615 | 1 063 273 | |
2018-12-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 22 | 12 397 | 0,18 | 68,78 | 1 513 | 852 690 | |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −782 | 6 709 | −10,44 | |||
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 718 | 0 | −100,00 | |||
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 12 375 | −16,81 | 104,50 | −261 250 | 1 293 188 |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 782 | 14 875 | 5,55 | 28,23 | 22 076 | 419 921 |
2018-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 718 | 14 093 | 13,88 | 28,23 | 48 499 | 397 845 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 491 | 1 718 | −59,18 | |||
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 491 | 12 375 | −16,76 | 99,50 | −247 854 | 1 231 312 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 491 | 14 866 | 20,13 | 28,23 | 70 321 | 419 667 |
2018-06-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −654 | 12 375 | −5,02 | 99,50 | −65 073 | 1 231 312 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 021 | 13 029 | −13,43 | 94,50 | −190 984 | 1 231 240 |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −346 | 15 050 | −2,25 | 92,07 | −31 856 | 1 385 654 | |
2018-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 450 | 15 396 | −13,73 | 89,50 | −219 275 | 1 377 942 |
2018-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 287 | 17 846 | 1,63 | 68,78 | 19 740 | 1 227 484 | |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −414 | 17 559 | −2,30 | 81,36 | −33 683 | 1 428 600 | |
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −346 | 12 263 | −2,74 | 84,10 | −29 099 | 1 031 318 | |
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 9 120 | 9 120 | |||||
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 710 | 17 973 | 46,56 | ||||
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −309 | 12 609 | −2,39 | 83,57 | −25 823 | 1 053 734 | |
2018-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 33 | 12 918 | 0,26 | 69,78 | 2 303 | 901 379 | |
2018-01-09 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 84 705 | 84 705 | |||||
2018-01-09 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 84 705 | 84 705 | |||||
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 671 | 0 | −100,00 | |||
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 671 | 12 885 | −17,17 | 100,00 | −267 100 | 1 288 500 |
2017-06-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 671 | 15 556 | 20,73 | 21,51 | 57 453 | 334 610 |
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 12 885 | −2,84 | 90,72 | −34 111 | 1 168 927 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 13 261 | −1,54 | 91,50 | −18 940 | 1 213 382 | |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 600 | 2 671 | −49,33 | |||
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 600 | 13 468 | −16,18 | 93,17 | −242 242 | 1 254 814 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 600 | 16 068 | 19,31 | 21,51 | 55 926 | 345 623 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −4 882 | 13 468 | −26,60 | 91,17 | −445 092 | 1 227 878 |
2017-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 270 | 18 350 | 1,49 | 70,30 | 18 982 | 1 290 078 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 7 740 | 7 740 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 790 | 18 080 | 36,04 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 13 290 | −2,75 | 90,96 | −34 201 | 1 208 858 | |
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −336 | 13 666 | −2,40 | 92,50 | −31 080 | 1 264 105 | |
2017-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 62 | 14 002 | 0,44 | 68,42 | 4 242 | 958 045 | |
2016-08-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −287 | 14 260 | −1,97 | 100,00 | −28 700 | 1 426 000 |
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 14 547 | −2,52 | 90,00 | −33 840 | 1 309 230 | |
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 14 923 | −1,37 | 82,71 | −17 121 | 1 234 281 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 15 130 | −2,85 | 80,80 | −35 875 | 1 222 504 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 327 | 15 574 | 2,14 | 51,26 | 16 763 | 798 386 | |
2016-04-29 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 41 379 | 41 379 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −376 | 15 247 | −2,41 | 80,34 | −30 208 | 1 224 944 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 7 000 | 7 000 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 3 570 | 15 623 | 29,62 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 127 | 12 053 | 1,06 | 51,26 | 6 510 | 617 879 | |
2015-12-24 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Common stock |
M - Exercise | 10 000 | 10 000 | 2,89 | 28 900 | 28 900 | ||
2015-12-24 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
M - Exercise | −10 000 | 2 500 | −80,00 | ||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −522 | 11 926 | −4,19 | 120,46 | −62 880 | 1 436 606 | |
2015-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −308 | 12 448 | −2,41 | 125,57 | −38 676 | 1 563 095 | |
2015-05-22 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 28 846 | 28 846 | |||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 12 756 | −1,60 | 122,78 | −25 415 | 1 566 182 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 12 963 | −3,31 | 121,66 | −54 017 | 1 577 079 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 607 | 13 407 | 4,74 | 51,26 | 31 117 | 687 290 | |
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 9 000 | 9 000 | |||||
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 000 | 12 800 | 45,45 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 10 000 | 10 000 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 000 | 8 800 | 83,33 | ||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 000 | 8 800 | −44,30 | 109,46 | −766 210 | 963 235 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 7 000 | 15 800 | 79,55 | 28,23 | 197 610 | 446 034 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −7 000 | 7 491 | −48,31 | ||||
2015-01-02 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −5 000 | 14 491 | −25,65 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 4 593 | −52,12 | 91,82 | −459 100 | 421 729 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 000 | 9 593 | 108,86 | 28,23 | 141 150 | 270 810 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −6 429 | 0 | −100,00 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | −521 | 0 | −100,00 | ||||
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −6 950 | 4 593 | −60,21 | 90,25 | −627 238 | 414 518 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 6 429 | 11 543 | 125,71 | 21,51 | 138 288 | 248 290 | |
2014-12-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 521 | 5 114 | 11,34 | 14,39 | 7 497 | 73 590 | |
2014-12-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 400 | 4 593 | −42,54 | 88,97 | −302 508 | 408 653 | |
2014-08-04 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2014-08-04 |
|
4 | ANTH |
Anthera Pharmaceuticals Inc
Stock Option (right to buy) |
A - Award | 18 750 | 18 750 | |||||
2014-06-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −297 | 7 993 | −3,58 | 57,96 | −17 214 | 463 274 | |
2014-05-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −207 | 8 290 | −2,44 | 57,44 | −11 890 | 476 178 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −282 | 8 497 | −3,21 | 59,30 | −16 723 | 503 872 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −444 | 8 281 | −5,09 | 56,78 | −25 210 | 470 195 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 498 | 8 779 | 6,01 | 29,69 | 14 786 | 260 649 | |
2014-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 278 | 8 725 | 3,29 | 27,91 | 7 758 | 243 475 | |
2013-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −413 | 8 447 | −4,66 | 62,70 | −25 895 | 529 627 | |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 12 900 | 12 900 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 2 200 | 8 860 | 33,03 | ||||
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −3 500 | 6 429 | −35,25 | 21,51 | −75 285 | 138 288 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 500 | 6 660 | −34,45 | 70,33 | −246 155 | 468 398 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 500 | 10 160 | 52,55 | 21,51 | 75 285 | 218 542 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 447 | 6 660 | −17,85 | 70,41 | −101 890 | 468 961 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −479 | 8 924 | −5,09 | 65,32 | −31 288 | 582 916 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −817 | 8 107 | −9,16 | 67,68 | −55 295 | 548 682 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −4 874 | 521 | −90,34 | ||||
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 500 | 9 403 | −44,37 | 67,11 | −503 295 | 630 998 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 7 500 | 16 903 | 79,76 | 21,51 | 161 325 | 363 584 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −7 500 | 15 200 | −33,04 | ||||
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 457 | 9 403 | −32,16 | 65,48 | −291 858 | 615 737 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 874 | 13 860 | −26,02 | 65,35 | −318 496 | 905 696 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 874 | 18 734 | 35,17 | 14,39 | 70 137 | 269 582 | |
2013-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 581 | 13 860 | 4,38 | 23,20 | 13 482 | 321 621 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 605 | 63 595 | −5,36 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −730 | 67 200 | −1,07 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −688 | 67 930 | −1,00 | ||||
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | 2 015 | 13 279 | 17,89 | 59,81 | 120 510 | 794 171 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 023 | 15 294 | −24,72 | 59,74 | −300 067 | 913 642 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 605 | 20 317 | 21,57 | 14,39 | 51 876 | 292 362 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 730 | 16 712 | 4,57 | 17,86 | 13 038 | 298 476 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 688 | 15 982 | 4,50 | 38,59 | 26 550 | 616 745 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 548 | 15 294 | 3,72 | 21,76 | 11 924 | 332 797 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −290 | 14 746 | −1,93 | 35,64 | −10 336 | 525 547 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −574 | 15 036 | −3,68 | 38,00 | −21 812 | 571 368 | |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 312 | 68 618 | −13,06 | |||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 500 | 78 930 | −6,51 | |||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 812 | 15 340 | −50,76 | 50,00 | −790 600 | 767 000 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 312 | 31 152 | 49,48 | 38,59 | 397 940 | 1 202 156 |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 500 | 20 840 | 35,85 | 14,39 | 79 145 | 299 888 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −8 000 | 84 430 | −8,66 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 500 | 15 340 | −26,39 | 47,50 | −261 250 | 728 650 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 20 840 | −10,71 | 46,00 | −115 000 | 958 640 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 8 000 | 23 340 | 52,15 | 14,39 | 115 120 | 335 863 |
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −2 500 | 92 430 | −2,63 | |||
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 15 340 | −14,01 | 42,50 | −106 250 | 651 950 |
2012-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 17 840 | 16,30 | 14,39 | 35 975 | 256 718 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −2 770 | 94 930 | −2,84 | |||
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 770 | 15 340 | −15,30 | 40,00 | −110 800 | 613 600 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 770 | 18 110 | 18,06 | 17,86 | 49 472 | 323 445 |
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 150 | 2 462 | 6,49 | ||||
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −56 | 15 340 | −0,36 | 37,98 | −2 127 | 582 613 | |
2012-05-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 150 | 15 396 | 0,98 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 750 | 2 612 | 40,28 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | 812 | 3 362 | 31,84 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 750 | 15 246 | 5,17 | ||||
2012-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 812 | 14 496 | 5,93 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −375 | 97 700 | −0,38 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −625 | 98 075 | −0,63 | 37,50 | −23 438 | 3 677 812 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −4 291 | 98 700 | −4,17 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −417 | 102 991 | −0,40 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −10 000 | 103 408 | −8,82 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 11 800 | 113 408 | 11,61 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 708 | 13 684 | −53,44 | 37,50 | −589 050 | 513 150 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 375 | 29 392 | 1,29 | 17,89 | 6 709 | 525 823 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 625 | 29 017 | 2,20 | 17,89 | 11 181 | 519 114 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 291 | 28 392 | 17,80 | 17,33 | 74 363 | 492 033 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 417 | 24 101 | 1,76 | 17,54 | 7 314 | 422 732 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 10 000 | 23 684 | 73,08 | 11,74 | 117 400 | 278 050 | |
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 720 | 13 684 | 52,66 | ||||
2012-05-11 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 664 | 8 964 | 8,00 | 19,35 | 12 846 | 173 418 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −375 | 97 650 | −0,38 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −675 | 98 025 | −0,68 | 37,50 | −25 312 | 3 675 938 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −4 291 | 98 700 | −4,17 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −417 | 102 991 | −0,40 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −10 000 | 103 408 | −8,82 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 11 800 | 113 408 | 11,61 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 708 | 13 684 | −53,44 | 37,50 | −589 050 | 513 150 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 375 | 29 392 | 1,29 | 17,89 | 6 709 | 525 823 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 625 | 29 017 | 2,20 | 17,89 | 11 181 | 519 114 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 291 | 28 392 | 17,80 | 17,33 | 74 363 | 492 033 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 417 | 24 101 | 1,76 | 17,54 | 7 314 | 422 732 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 10 000 | 23 684 | 73,08 | 11,74 | 117 400 | 278 050 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 720 | 13 684 | 52,66 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 664 | 8 964 | 8,00 | 19,35 | 12 846 | 173 418 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 101 608 | −4,69 | ||||
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 8 300 | −37,59 | 35,06 | −175 325 | 291 040 | |
2012-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 000 | 13 300 | 60,24 | 11,74 | 58 700 | 156 142 | |
2012-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 964 | 8 300 | 13,14 | 13,23 | 12 750 | 109 776 |